Harmon Cyrus — SEC Form 4 filings
SEC reporting owner CIK 1831410. 18 Form 4 filings on record with FilingPulse; latest filed 2026-07-27.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2024-02-02 to 2026-07-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 26 legs across 15 filings — 232,763 shares, $2,819,085 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 24,900 shares @ $12.41 ($309,009) in Olema Pharmaceuticals, Inc., filed 2024-03-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | Director | 18 | — | 26 legs · 232,763 sh · $2,819,085 | 4 |
Form 4 filings — Harmon Cyrus
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-27 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 12,500 @ $11.58 · Sale (S): 12,500 @ $11.71 | EDGAR |
| 2026-06-23 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 29,500 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 10,000 @ $26.88 | EDGAR |
| 2026-01-16 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 3,489 @ $29.12 | EDGAR |
| 2025-12-29 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 2,881 @ $28.53 | EDGAR |
| 2025-09-18 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 10,000 @ $8.04 · Sale (S): 10,000 @ $8.33 · Sale (S): 1,914 @ $8.08 · Sale (S): 3,086 @ $8.32 | EDGAR |
| 2025-06-13 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 24,150 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 29,250 @ $0 · Sale (S): 8,256 @ $9.37 · Sale (S): 7,958 @ $8.66 · Sale (S): 179 @ $9.39 | EDGAR |
| 2024-07-31 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 4,066 @ $15.58 · Sale (S): 934 @ $15.55 | EDGAR |
| 2024-07-12 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 5,000 @ $12.26 | EDGAR |
| 2024-07-02 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 20,000 @ $10.77 | EDGAR |
| 2024-06-18 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 23,000 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 15,000 @ $9.41 · Sale (S): 5,000 @ $10.93 · Sale (S): 5,000 @ $12.33 | EDGAR |
| 2024-05-07 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 5,000 @ $10.92 | EDGAR |
| 2024-05-02 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 15,000 @ $9.51 | EDGAR |
| 2024-03-29 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 20,000 @ $10.97 | EDGAR |
| 2024-03-04 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 24,900 @ $12.41 · Sale (S): 100 @ $13 | EDGAR |
| 2024-02-02 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Sale (S): 25,000 @ $12.23 · Sale (S): 5,000 @ $15.56 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1831410 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →